CombinatoRx and Neuromed Sign Merger Agreement
By Taskin Ahmed
Pharma Deals Review: Vol 2009 Issue 7 (Table of Contents)
Published: 9 Jul-2009
DOI: 10.3833/pdr.v2009.i7.1133 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
CombinatoRx, a combination drugs developer, and Neuromed, which develops pain therapies, have agreed to merge in an all stock transaction with each party owning approximately 50%...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS